companies

Abridge

AI platform that turns patient-clinician conversations into structured clinical documentation.

Abridge builds generative AI technology that listens to patient-clinician conversations and transforms them into structured, billable clinical documentation in real time. The platform integrates with electronic health record systems and is used by clinicians, health systems, and payers to reduce documentation burden while surfacing clinical decision support informed by the conversation itself. Founded in 2018 by Dr. Shiv Rao, a practicing cardiologist formerly at UPMC, and Zachary Lipton, a former Carnegie Mellon University machine learning professor, Abridge is headquartered in Pittsburgh, Pennsylvania. The company has grown rapidly, reporting it is trusted by 300+ health systems and powers over 100 million patient conversations annually. Abridge has raised significant venture funding, including a $250 million Series D in February 2025 (led by Elad Gil and IVP, with CapitalG and NVentures participating) at a $2.8 billion valuation, followed by a $300 million Series E in June 2025 led by Andreessen Horowitz with participation from Khosla Ventures, valuing the company at $5.3 billion.

Founded

2018

Headquarters

Pittsburgh, United States

Sector

applications